Company press releases

Displaying 151 - 168 of 168 results
Released Company Title Industry Topic
22 Feb 2022
12:00 CET 		BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Total number of voting rights and capital
16 Feb 2022
17:10 CET 		BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Kapital- og stemmerettsendringer
16 Feb 2022
07:00 CET 		BERGENBIO BERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2021 20103010 Biotechnology Inside information
08 Feb 2022
07:00 CET 		BERGENBIO BERGENBIO ASA: INVITATION TO FOURTH QUARTER 2021 RESULTS WEBCAST 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Feb 2022
14:07 CET 		BERGENBIO BerGenBio ASA: Share capital increase 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
27 Jan 2022
20:56 CET 		BERGENBIO BerGenBio ASA: Increase of share capital, exercise of share options 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Jan 2022
07:00 CET 		BERGENBIO BerGenBio and Oslo University Hospital Announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded EU-SolidAct trial in Hospitalised COVID-19 Patients 20103010 Biotechnology Inside information
10 Jan 2022
19:52 CET 		BERGENBIO BerGenBio - Mandatory notification of trade by Primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jan 2022
17:51 CET 		BERGENBIO BerGenBio - Mandatory notification of trade by Primary Insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jan 2022
09:04 CET 		BERGENBIO BERGENBIO - Mandatory notification of trade by Primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
06 Jan 2022
10:30 CET 		BERGENBIO BERGENBIO APPOINTS ANDERS TULLGREN AS CHAIRMAN OF BOARD 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Jan 2022
10:27 CET 		BERGENBIO BerGenBio ASA: Extraordinary General Meeting held 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Jan 2022
08:58 CET 		BERGENBIO BerGenBio - Mandatory notification of trade by Primary Insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
17 Dec 2021
13:43 CET 		BERGENBIO Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Dec 2021
15:00 CET 		BERGENBIO BerGenBio ASA: Notice of Extraordinary General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Dec 2021
07:30 CET 		BERGENBIO BerGenBio announces exclusive in-license of key intellectual property rights from UT Southwestern Medical Center 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Dec 2021
07:43 CET 		BERGENBIO BerGenBio to present at DNB Nordic Healthcare Conference 2021 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Dec 2021
15:00 CET 		BERGENBIO BERGENBIO PRESENTS UPDATED BEMCENTINIB AML DATA AT ASH 2021 MEETING 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State